The Interleukin-6 -174G/C Polymorphism and Prostate Cancer Risk: A Systematic Review and Meta-Analysis
Urologia Internationalis, 06/14/2012
Evidence Based Medicine
Clinical Article
Zhang H et al. – The review suggest that –174G/C polymorphism is associated with an increased prostate cancer risk in two cohort studies from one article.



